Preferred Name |
taletrectinib |
Synonyms |
3-(4-((2R)-2-aminopropoxy)phenyl)-N-((1R)-1-(3-fluorophenyl)ethyl)imidazo(1,2-b)pyridazin-6-amine;hexanedioic acid |
ID |
http://purl.bioontology.org/ontology/MESH/C000720459 |
altLabel |
3-(4-((2R)-2-aminopropoxy)phenyl)-N-((1R)-1-(3-fluorophenyl)ethyl)imidazo(1,2-b)pyridazin-6-amine;hexanedioic acid |
cui |
C5418160 C5565843 |
HM |
D011724 D007093 |
Inverse of RB |
W4141180YD |
Mapped to | |
MDA |
20211215 |
MeSH Frequency |
1 |
MMR |
20211215 |
notation |
C000720459 |
prefLabel |
taletrectinib |
SC |
1 |
Scope Statement |
type I ROS1-NTRK inhibitor |
SRC |
Clin Cancer Res . 2020 Sep 15;26(18):4785-4794. |
TERMUI |
T001116061 T001116059 |
TH |
NLM (2022) |
tui |
T109 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C118948 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |